Efficacy and safety of osilodrostat in patients with ectopic Cushing’s syndrome

Hormones · Published 2026-07-17 · DOI 10.1007/s42000-026-00806-y

Authors (4)

Marta Araujo-Castro, Oriana Arroyo-Ripoll, Jorge Contreras-Saldarriaga, Betina Biagetti

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Araujo-Castro, M., Arroyo-Ripoll, O., Contreras-Saldarriaga, J., et al. (2026). Efficacy and safety of osilodrostat in patients with ectopic Cushing’s syndrome. Hormones. https://doi.org/10.1007/s42000-026-00806-y

Related articles

• Pseudohypoaldosterism: demystification using network medicine and proposed diagnostic panels · Hormones · 2026 · Same journal
• Exploring the relationship between oxidative balance score and sex hormone levels in American males: a cross-sectional study · Hormones · 2026 · Same journal
• Exploring the effects of exogenous interleukin-18 on islet function and immune mechanisms in type 1 diabetic mice · Hormones · 2026 · Same journal
• Professor Petros S. Kokkalis (1896-1962) and the evolution of thyroid disease understanding in early 20th century Greek medicine · Hormones · 2026 · Same journal
• Advances in diabetes technology: clinical implications, limitations, and future perspectives · Hormones · 2026 · Same journal
• Association between serum vitamins and sex hormone levels in adolescent males: based on the National Health and Nutrition Examination Survey (NHANES) · Hormones · 2026 · Same journal
• Deciphering the obesity paradox in phenotypic age acceleration through thyroid hormone sensitivity: results from NHANES 2007–2010 · Hormones · 2026 · Same journal
• Exogenous parathyroid hormone (1–34) attenuates knee osteoarthritis in mice through activating the TGF-β/Smad signaling pathway · Hormones · 2026 · Same journal
• The influence of the Mediterranean dietary pattern on male and female sexual dysfunctions: an updated review · Hormones · 2026 · Same journal
• Association of AGAHR with metabolic dysfunction-associated steatotic liver disease (MASLD) · Hormones · 2026 · Same journal